Mendizabal V E, Poblete I, Lomniczi A, Rettori V, Huidobro-Toro J P, Adler-Graschinsky E
Instituto de Investigaciones Farmacológicas (ININFA-CONICET), Junín 956 5, 1113, Buenos Aires, Argentina.
Eur J Pharmacol. 2000 Dec 1;409(1):85-91. doi: 10.1016/s0014-2999(00)00789-5.
The aim of the present study was to test whether the contractile responses elicited by KCl in the rat mesenteric bed are coupled to the release of nitric oxide (NO). Contractions induced by 70 mM KCl were coincident with the release of NO to the perfusate. The in vitro exposure to the nitric oxide synthase (NOS) inhibitor L-N(omega)-nitro-L-arginine methyl ester, L-NAME (1-100 microM) potentiated the vascular responses to 70 mM KCl and, unexpectedly, increased the KCl-stimulated release of NO. Moreover, even after the chronic treatment with L-NAME (70 mg/kg/day during 4 weeks), the KCl-induced release of NO was not reduced, whereas the potentiation of contractile responses was indeed achieved. The possibility that NOS had not been completely inhibited under our experimental conditions can be precluded because NOS activity was significantly inhibited after both L-NAME treatments. After the in vitro treatment with 1 to 100 microM L-NAME, the inhibition of NOS was concentration-dependent (from 50% to 90%). With regard to the basal release of NO, the inhibition caused by L-NAME was not concentration-dependent and reached a maximum of 40%, suggesting that basal NO outflow is only partially dependent on NOS activity. An eventual enhancement of NOS activity caused by KCl was disregarded because the activity of this enzyme measured in homogenates from mesenteric beds perfused with 70 mM KCl was significantly reduced. On the other hand, endothelium removal, employed as a negative control, almost abolished NOS activity, whereas the incubation with the Ca(2+) ionophore A23187, employed as a positive control, induced an increase in NOS activity. It is concluded that in the mesenteric arterial bed of the rat, the contractile responses elicited by depolarization through KCl are coincident with a NOS-independent release of NO. This observation, which differs from the results obtained with noradrenaline, do not support the use of KCl as an alternative contractile agent whenever the participation of NO is under study.
本研究的目的是检测氯化钾在大鼠肠系膜床引发的收缩反应是否与一氧化氮(NO)的释放相关联。70 mM氯化钾诱导的收缩与向灌注液中释放NO同时发生。在体外暴露于一氧化氮合酶(NOS)抑制剂L-N(ω)-硝基-L-精氨酸甲酯,L-NAME(1-100 μM)可增强血管对70 mM氯化钾的反应,并且出乎意料的是,增加了氯化钾刺激的NO释放。此外,即使在长期用L-NAME(70 mg/kg/天,持续4周)治疗后,氯化钾诱导的NO释放也没有减少,而收缩反应的增强确实得以实现。由于在两种L-NAME处理后NOS活性均被显著抑制,因此可以排除在我们的实验条件下NOS未被完全抑制的可能性。在用1至100 μM L-NAME进行体外处理后,NOS的抑制呈浓度依赖性(从50%至90%)。关于NO的基础释放,L-NAME引起的抑制不呈浓度依赖性,最大抑制率为40%,这表明基础NO流出仅部分依赖于NOS活性。由于在用70 mM氯化钾灌注的肠系膜床匀浆中测得的该酶活性显著降低,因此排除了氯化钾导致NOS活性最终增强的可能性。另一方面,作为阴性对照的内皮去除几乎消除了NOS活性,而作为阳性对照的与Ca(2+)离子载体A23187孵育则诱导了NOS活性增加。得出的结论是,在大鼠肠系膜动脉床中,通过氯化钾去极化引发的收缩反应与不依赖NOS的NO释放同时发生。这一观察结果与用去甲肾上腺素获得的结果不同,不支持在研究NO参与情况时将氯化钾用作替代收缩剂。